Acknowledgements & Disclosures

The following speakers, reviewers, and planning committee members have disclosed the following:

  • Euan A. Ashley, BSc, MB, ChB, FRCP, DPhil, FAHA, FACC, FESC has disclosed that is a consult for Myokardia.
  • William S. Dalton, M.D., Ph.D.  has disclosed that he is employed by M2Gen, a for-profit health information solutions company.
  • David DeRemer, Pharm.D., BCOP, FCCP has disclosed that he is on the advisory board for Amgen.
  • Carlos Alejandro Diaz Tufinia, PhD, MSC has disclosed that he receives grant/research support from Alix Clinicals Latina.
  • Mark Dunnenberger, Pharm.D., BCPS has disclosed that he is a consultant for Veritas Genetics and Admera Health.
  • Mia Mehanna, MS has disclosed that she receives grant/research support from the National Institute of Health Pharmaogenetics Research.
  • Howard McLeod, PharmD. has disclosed he is a consultant for Viecure, affiliated with the Genentech speakers bereau, and a shareholder for Cancer Genetics and Interpares Biomedicine.
  • Duane A. Mitchell, MD, PhD has disclosed that he receives grant/research support from Immunomic Therapeutics and is a consultant for Bristol Myers-Squibb, Tocagen, and Oncarus.  He also holds shares in iOncologi, Inc., and receives other financial or material support from Annias Immunotherapeutics and Celldex Therapuetics

The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

  • Meghan J. Arwood, Pharm.D., BCPS has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Jeffrey Bishop, Pharm.D., M.S., BCPS, FCCP has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Adam H. Buchanan, M.S., MPH, CGC has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Larisa Cavallari, Pharm. D. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Emily Cicali, Pharm.D. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Christopher R. Cogle, M.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Rhonda Cooper-DeHoff, Pharm.D., M.S., FAHA, FACC has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Kristine Crews, Pharm.D. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Joshua Charles Denny, MD, MS has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Rachel Dalton Pharm.D, MS has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Julio Duarte, Pharm.D., Ph.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Benjamin Duong, Pharm.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Nihal El Rouby Pharm.D, PhD   has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Vanessa Gonzalez-Covarrubias, PhD has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Susanne Haga, Ph.D. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Carol Horowitz, M.D. MPH  has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Peter J. Hulick, M.D., MMSc has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Julie Johnson, Pharm.D has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Jason H. Karnes, Pharm.D., Ph.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Ann Moyer, M.D., Ph.D. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • David R. Nelson, M.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Alexander Parker, Ph.D., M.S. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Hari K. Parvataneni, M.D. has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Sonja A. Rasmussen, M.D., M.S. has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Marci Schwartz, M.S., LGC has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Nathan Seligion, Pharm.D has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Sonal Singh, Pharm.D has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • D. Maxwell Smith III, PharmD, BCPS has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Lauren B. Solberg, J.D., MTS has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Bianca A Torres-Hernández, PhD has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Cameron Thomas, Pharm.D has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Christine Walko, PharmD, BCOP, FCCP has disclosed that he has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
  • Kristin Wiisanen, Pharm.D., FAPhA has disclosed that she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.